Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for Colorectal Adenoma Prevention in Lynch Syndrome
NCT02813824Phase 3Active, not recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2017
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in Colorectal Adenoma (CRA), sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2017; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
Colorectal Adenoma (CRA)
Beyond the preview
Go deeper on NCT02813824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02813824.